Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111.5 GBX | +0.90% | -0.89% | -2.19% |
Apr. 23 | Alchemy Special Opportunities plans to sell 25 million Mitie shares | AN |
Apr. 03 | AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal | AN |
Valuation
Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 152.3 | 130.2 | 136.9 | - | - |
Enterprise Value (EV) 1 | 152.3 | 130.2 | 136.9 | 136.9 | 136.9 |
P/E ratio | 7.09 x | -96.4 x | -58.7 x | 279 x | 13.6 x |
Yield | 2.5% | - | - | 0.09% | 2.96% |
Capitalization / Revenue | 1.16 x | 1.58 x | 1.6 x | 1.47 x | 1.23 x |
EV / Revenue | 1.16 x | 1.58 x | 1.6 x | 1.47 x | 1.23 x |
EV / EBITDA | - | - | - | - | - |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | 0.88 x | 1.37 x | 1.49 x | 1.49 x | 1.36 x |
Nbr of stocks (in thousands) | 122,807 | 122,807 | 122,807 | - | - |
Reference price 2 | 1.240 | 1.060 | 1.115 | 1.115 | 1.115 |
Announcement Date | 6/9/22 | 6/16/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 131 | 82.34 | 85.6 | 93 | 111.5 |
EBITDA | - | - | - | - | - |
EBIT | - | - | - | - | - |
Operating Margin | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 29.04 | -1.488 | -2.6 | 0.6 | 13.2 |
Net income 1 | 21.47 | -1.322 | -2.3 | 0.4 | 9.9 |
Net margin | 16.38% | -1.61% | -2.69% | 0.43% | 8.88% |
EPS 2 | 0.1748 | -0.0110 | -0.0190 | 0.004000 | 0.0820 |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share 2 | 0.0310 | - | - | 0.001000 | 0.0330 |
Announcement Date | 6/9/22 | 6/16/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2023 S1 |
---|---|
Net sales 1 | 41.07 |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) 1 | 0.061 |
Net income | - |
Net margin | - |
EPS | - |
Dividend per Share | - |
Announcement Date | 12/1/22 |
Balance Sheet Analysis
Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | 34.4% | -1.37% | -2.5% | 0.5% | 10.4% |
ROA (Net income/ Total Assets) | 3.52% | -0.2% | -0.5% | 0.1% | 1.5% |
Assets 1 | 609.2 | 661 | 460 | 400 | 660 |
Book Value Per Share 2 | 1.410 | 0.7700 | 0.7500 | 0.7500 | 0.8200 |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 6/9/22 | 6/16/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.19% | 171M | |
-6.03% | 113B | |
-3.98% | 87.91B | |
+20.42% | 63.85B | |
+5.29% | 61.9B | |
+10.12% | 42.86B | |
+7.95% | 40.84B | |
+18.92% | 34.58B | |
+5.88% | 25.46B | |
-5.25% | 22.13B |
- Stock Market
- Equities
- PEEL Stock
- Financials Peel Hunt Limited